Concepedia

Anne Bollaerts

AB

Statistics

Publications

10

Citations

1.5K

H-Index

10

Active since

2013

Affiliations

GlaxoSmithKline (Belgium)(Current)

Kenya Medical Research Institute

University of Cape Town

South African Tuberculosis Vaccine Initiative

Johns Hopkins University

Anne Bollaerts is an author at GlaxoSmithKline (Belgium) specializing in vaccine safety, tuberculosis, and medicine.

Top concepts

Publications per year

2013–2022

10

Publications

10

Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 561 citations · Full text

Phase 2b Controlled Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba et al. · New England Journal of Medicine · 2018 · 392 citations · Full text

Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults

Cheryl L. Day, Michèle Tameris, Nazma Mansoor et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 115 citations

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults

Jaime Montoya, Juan Antonio Solon, Soledad Rosanna C. Cunanan et al. · Journal of Clinical Immunology · 2013 · 96 citations · Full text

Safety and immunogenicity of the M72/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study

Paul Gillard, Pan‐Chyr Yang, Manfred Danilovitš et al. · Tuberculosis · 2016 · 75 citations · Full text

, , +11

1–5 of 10